AstraZeneca Says Arimidex More Effective Than Tamoxifen
434863
The ATAC (Arimidex, tamoxifen, alone or in combination) trial is the largest and longest-running early breast cancer treatment study.
749459
A new type of breast cancer drug is clearly superior to the old standard, tamoxifen, in many women and should now be the first drug used to treat the cancer, U.S. and British researchers said on Wednesday.
726448
AstraZeneca Plc&#39;s cholesterol-lowering drug Crestor performed better than Pfizer Inc&#39;s Lipitor in an AstraZeneca-funded study of patients with metabolic syndrome, according to results released on Monday.
415904
LONDON - Arimidex, one of a new class of breast cancer drugs, has clearly beaten standard treatment tamoxifen at preventing breast cancer from returning in a 5-year study, researchers said on Wednesday.
57060
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option yesterday with the approval of a novel drug -- but how much benefit it offers is unclear.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
730766
THE REPORT: Doctors are reporting that a new breast cancer drug outperforms the tried-and-true tamoxifen at preventing the disease from recurring.
599909
NEW YORK  - In premenopausal women with fibroids, the breast cancer drug anastrozole (Arimidex) reduces fibroid size and improves bothersome symptoms, according to results of a prospective study conducted at the Aristotle University of Thessaloniki in Greece.
95999
A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
101669
A new analysis finds that clinical trials of breast-cancer treatments by drugmakers show positive results far more often than non-industry trials. Why the difference?
446242
Raloxifene (Evista) continues to be associated with more than a 50% reduction in breast cancer incidence beyond the first 4 years of treatment, according to a new study in the December 1 issue of the Journal of the National Cancer Institute.
453467
Shorter courses of chemotherapy taken  with Roche Holding AG's cancer drug MabThera are as effective  as longer courses in elderly patients with aggressive lymphoma,  a study in The Lancet Oncology showed.
139693
Postmenopausal women with early breast cancer who take tamoxifen for five years appear to have a 30 percent lower risk of dying from coronary heart disease than
280952
Gilead Sciences on Thursday said preliminary data from a 48-week trial show that two of its two drugs, Viread and Emtriva, were better able to control levels of HIV than Combivir, a popular treatment sold by GlaxoSmithKline Plc.
672458
A new type of cancer drug being developed by Bristol-Myers Squibb Co., when combined with a standard chemotherapy, was significantly better than chemotherapy alone in delaying progression of advanced breast cancer, a researcher said on Sunday.
458471
12/8/04- the drug tamoxifen has long been the 1st line of therapy for preventing the return of breast cancer, but researchers say another drug may be more effective and could soon become the 1st choice treatment for post-menopausal women who&#39;ve had the
31407
A new type of breast cancer drug is  superior to the old standard, tamoxifen, in older women and  should now be the first drug used to treat the cancer, U.S. and  British researchers said on Wednesday.